-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Azrz6Cv06jabJDiwlsHQWzsBRto6XGMzaG47BTdzuZZTu1ZbFT/DHlyt8av5ixzS QzFH+j+YlVgprvhF0kVZag== 0001140361-10-037939.txt : 20100920 0001140361-10-037939.hdr.sgml : 20100920 20100920115908 ACCESSION NUMBER: 0001140361-10-037939 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100913 FILED AS OF DATE: 20100920 DATE AS OF CHANGE: 20100920 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Csimma Cristina CENTRAL INDEX KEY: 0001501623 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10352 FILM NUMBER: 101079881 MAIL ADDRESS: STREET 1: 14 CAMBRIDGE CENTER, BLDG 1 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLUMBIA LABORATORIES INC CENTRAL INDEX KEY: 0000821995 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 592758596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 354 EISENHOWER PARKWAY CITY: LIVINGSTON STATE: NJ ZIP: 07039 BUSINESS PHONE: 9739943999 MAIL ADDRESS: STREET 1: 354 EISENHOWER PARKWAY CITY: LIVINGSTON STATE: NJ ZIP: 07039 3 1 doc1.xml FORM 3 X0203 3 2010-09-13 0 0000821995 COLUMBIA LABORATORIES INC CBRX 0001501623 Csimma Cristina 354 EISENHOWER PARKWAY LIVINGSTON NJ 07039 1 0 0 0 Common Stock, par value $0.01 per share 28037 D Restricted stock award granted on September 15, 2010, and vests at next annual meeting of stockholders. /s/ Michael McGrane for Cristina Csimma 2010-09-20 EX-24.1 2 poa1.htm POWER OF ATTORNEY Unassociated Document
 







Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
Attn: Filing Desk




Ladies and Gentlemen:

By means of this letter, I authorize Michael McGrane and Lawrence A. Gyenes, or either of them individually, to sign on my behalf all forms required under Section 16(a) of the Securities Exchange Act of 1934, as amended, relating to transactions involving the stock or derivative securities of Columbia Laboratories, Inc.  Either such individual is accordingly authorized to sign any Form 3, Form 4, Form 5, or amendment thereto, that I am required to file with the same effect as if I had signed it myself.

This authorization, signed this 15th day of September, 2010, shall remain in effect until revoked in writing by me. This authorization revokes all prior authorizations by me relating to the subject matter hereof.


Yours truly,



/S/ Cristina Csimma                                           
Cristina Csimma, PharmD
Director


 -----END PRIVACY-ENHANCED MESSAGE-----